The annuity model has led to slow organic growth, hence the reason why we adopted the aggressive acquisition strategy (voracious appetite) and diversified our revenue streams. This was stated in the goals for 2010, why is anybody surprised now?! People forgetting these small, but important details tells me they have very little on the line. Ive had around $40K in this at one point so I follow this very closely and very little info gets past me. If we buy Cryo-Mexico, we are more than likely profitable. If we buy ALL of Cryo-Cell, which I believe will still happen, what will we be? We will be a very profitable company with a corrected share structure and over $100M in leverageable cash. Everything is pointing in the direction of us TAKING OVER Cryo-Cell and I am sticking with that. We have the funds and/or financial backing as verified by our 2 offers in Dec 2010. If others choose to believe different, that's there choice. we are still a developmental stage company on the BB; we will not have 100% of the information we need to make any decisions with upmost certainty; all we can do is take what we have to work with and go with your gut. IMO, I feel like I have more than enough info to work with; others may differ.
Market Data 
Markets 
AI
